Profeta M L, Bigatello A, Vacchini V, Bramati L, Ferrante P
Boll Ist Sieroter Milan. 1980 Jan 31;58(6):457-74.
Three hundred eight subjects (of whom 103 children aged 6-12 years) were vaccinated with trivalent--A/USSR/90/77 (H1N1), A/Texas/1/77 (H3N2), B/Hong Kong/8/73 strains--influenza virus vaccines, two of them sub-unit and the third whole-virus preparation. Children and adolescent received two doses with an interval of 4 weeks, adults one dose only. The results of the determination by single radial diffusion test of the hemagglutinin amount for each of the three vaccinal strains and the data of the mouse immunogenicity test show that the antigenic content of A/USSR/90/77 strain in the sub-unit preparations was lower than expected from the concentration in I.U. reported by the vaccine manufacturers. Therefore it is pointed out the necessity to control the antigenic content of inactivated influenza virus vaccines with methods more adequate than those currently adopted. Sub-unit vaccines were much less reactogenic than the whole-virus preparation particularly in the youngest group of vaccinees. The immunogenicity (assessed by serum h.i.a. titers) of sub-unit vaccines, even after a single dose, turned out to be good and equal to that of the whole-virus preparation in primed subjects. In unprimed individuals, as it is shown by the data relative to the A/USSR/90/77 strain in sero-negative children, a two dose regimen is required. In these vaccines the whole-virus vaccine was more immunogenic than the sub-unit preparations, probably because of the lower content in the H1N1 strain of the latter. The increase from 1 ml (1 dose) to 1.6 ml the amount of vaccine, as experimented in adults with one sub-unit preparation, was not followed by an increase in reactogenicity. The larger dose did not influence the antibody response of primed subjects. On the contrary in unprimed vaccinees, as the youngest under 24 years without preexisting antibodies to the H1N1 strain in the present trial, the higher antigenic content produced a marked positive effect.
308名受试者(其中103名是6至12岁的儿童)接种了三价流感病毒疫苗——A/苏联/90/77(H1N1)、A/德克萨斯/1/77(H3N2)、B/香港/8/73毒株,其中两种是亚单位疫苗,第三种是全病毒制剂。儿童和青少年接种两剂,间隔4周,成人仅接种一剂。通过单向辐射扩散试验测定三种疫苗毒株各自血凝素含量的结果以及小鼠免疫原性试验的数据表明,亚单位制剂中A/苏联/90/77毒株的抗原含量低于疫苗生产商报告的国际单位浓度预期值。因此指出,有必要用比目前采用的方法更合适的方法来控制灭活流感病毒疫苗的抗原含量。亚单位疫苗的反应原性比全病毒制剂小得多,尤其是在最年幼的疫苗接种组中。亚单位疫苗的免疫原性(通过血清血凝抑制抗体滴度评估),即使单剂量接种后,也表现良好,与已接种过疫苗的受试者中全病毒制剂的免疫原性相当。在未接种过疫苗的个体中,正如血清阴性儿童中与A/苏联/90/77毒株相关的数据所示,需要接种两剂。在这些疫苗中,全病毒疫苗比亚单位制剂更具免疫原性,可能是因为后者的H1N1毒株含量较低。在成人中用一种亚单位制剂进行试验,将疫苗剂量从1毫升(1剂)增加到1.6毫升,并未导致反应原性增加。较大剂量并未影响已接种过疫苗的受试者的抗体反应。相反,在未接种过疫苗的受试者中,如本试验中24岁以下且对H1N1毒株无预先存在抗体的最年幼者,较高的抗原含量产生了显著的积极效果。